Investment Summary

Keensight Capital Invests In Lisam Systems

On June 21, 2022, private equity firm Keensight Capital invested in software company Lisam Systems

Investment Highlights
  • This is Keensight Capital’s 4th transaction in the Software sector.
  • This is Keensight Capital’s 1st transaction in Belgium.

Investment Summary
Date 2022-06-21
Target Lisam Systems
Sector Software
Investor(s) Keensight Capital
Deal Type Growth Capital

Target

Lisam Systems

Ecaussinnes, Belgium
Lisam Systems is a global provider of Environmental, Health and Safety (EH&S) compliance management software solutions and services, addressing more than 2,000 clients operating across various industries worldwide, including chemicals, detergents, paints and coatings, industrial and specialty gases, and fragrances. Lisam Systems was founded in 1999 and is based in Ecaussinnes, Belgium.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Keensight Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 5.5B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Keensight Capital is a private equity investment firm focused on majority and minority growth capital investments in Western European companies. Keensight makes equity investments in a number of situations including the provision of capital to finance growth, either organically or through acquisitions, or the buying out of existing shareholders. The Firm looks to invest €10 to €600 million and will consider business with up to €400 million in revenue. Keensight Capital was formed in 2000 and is based in Paris.

DEAL STATS #
Overall 37 of 50
Sector (Software) 4 of 10
Type (Growth Capital) 10 of 12
Country (Belgium) 1 of 1
Year (2022) 4 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-15 CatSci

Cardiff, United Kingdom

CatSci is an innovation partner for medicines development, dedicated to developing economically and environmentally sustainable pharmaceutical manufacturing processes. CatSci was founded in 2010 and is based in Cardiff, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-22 BYG4lab

L'Union, France

BYG4lab is a software publisher specializing in medical biology middleware solutions. The Company provides a number of key benefits, including but not limited to: improving workflow management, making instrument integration more efficient, handling mega lab configuration, designing personalized dashboards, maximizing automatic validation, and managing quality control. The Company addresses both Central Lab and Point of Care testing, as well as all disciplines in the field of medical biology – immunochemistry, hematology, molecular, microbiology. BYG4lab was founded in 1982 and is based in L'Union, France.

Buy -
Mergr

Product

Company

Legal